MedPath

Combinase

Brand Name: Combinase

Generic Name: Phenylpropanolamine Hydrochloride + Brompheniramine Maleate

Active
Registration Number

DRP-1918-01

Dosage Form

Syrup

Issuance Date

May 31, 2024

Expiry Date

May 21, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength12.5 mg/4 mg PER 5 mL
PackagingAmber Bottle x 60mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Decongestant / Antihistamine
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Phenylpropanolamine HydrochlorideActive
Brompheniramine MaleateActive
Monograph: Brompheniramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform